The Polymeal: A more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%

British Medical Journal

Volumn 329, Issue 7480, 2004, Pages 1447-1450

  Franco, Oscar H ^a   Bonneux, Luc ^b   De Laet, Chris ^a   Peeters, Anna ^c   Steyerberg, Ewout W ^a   Mackenbach, Johan P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BELGIAN HEALTH CARE KNOWLEDGE CENTRE KCE   (Belgium)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOND; ARTICLE; CACAO; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; FISH; FOOD COMPOSITION; FRUIT; GARLIC; HUMAN; LIFE EXPECTANCY; LIFE TABLE; MAJOR CLINICAL STUDY; MALE; MEAL; POLYMEAL; PRIORITY JOURNAL; VEGETABLE; WINE;

EID: 10844273039     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.329.7480.1447     Document Type: Article

References (21)

1. Gluckman TJ, Baranowski B, Ashen MD, Henrikson CA, McAllisier M, Braunstein JB, et al. A practical and evidence-based approach to cardiovascular disease risk reduction. Arch Intern Med 2004;164:1490-500.
2. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419-23.
3. Correspondence. "Polypill" to fight cardiovascular disease. BMJ 2003;327:807-10.
4. Sacket DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine: how to practice and teach EBM. New York: Churchill Livingstone, 2000.
5. Oxford Centre for Evidence Based Medicine. Levels of evidence and grades of recommendation. www.cebm.net/levels_of_evidence.asp (accessed 5 Aug 2004).
6. Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, De Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 2002;105:2836-44.
7. Whelton SP, He J, Whelton PK, Muntner P. Meta-analysis of observational studies on fish intake and coronary heart disease. Am J Cardiol 2004;93:1119-23.
8. Taubert D, Berkels R, Roesen R, Klaus W. Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA 2003;290:1029-30.
9. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000;356:1955-64.
10. John JH, Ziebland S, Yudkin P, Roe LS, Neil HA. Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial. Lancet 2002;359:1969-74.
11. Ackermann RT, Mulrow CD, Ramirez G, Gardner CD, Morbidoni L, Lawrence VA. Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med 2001;161:813-24.
12. Silagy C, Neil A. Garlic as a lipid lowering agent-a meta-analysis. J R Coll Physicians Lond 1994;28:39-45.
13. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994;308:367-72.
14. Berthold HK, Sudhop T, von Bergmann K. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized controlled trial. JAMA 1998;279:1900-2.
15. Jenkins DJ, Kendall GW, Marchie A, Parker TL, Connelly PW, Qian W, et al. Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial. Circulation 2002;106:1327-32.
16. Sabate J, Haddad E, Tanzman JS, Jambazian P, Rajaram S. Senim lipid response to the graduated enrichment of a step I diet with almonds: a randomized feeding trial. Am J Clin Nutr 2003;77:1379-84.
17. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham study. Am J Public Health 1951;41:279-81.
18. Stokes J 3rd, Kannel WB, Wolf PA, Cupples LA, D'Agostino RB. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham study. Circulation 1987;75:V65-73.
19. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2003;24:1601-10.
20. Peeters A, Mamun AA, Willekens F, Bonneux L. A cardiovascular life history: a life course analysis of the original Framingham heart study cohort. Eur Heart J 2002;23:458-66.
21. US Department of Health and Human Services. Physical activity and health: a report of the surgeon general. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 1996.